| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 22 | +31.82% | +4.19% | +0.80% | +3.39% | +2.45% | — |
| 14d | 22 | +27.27% | +6.20% | +0.44% | +5.76% | +8.96% | — |
| 30d | 22 | +54.55% | -2.92% | -1.14% | -1.78% | +0.71% | — |
| 60d | 22 | +54.55% | -1.36% | +2.27% | -3.63% | -2.69% | — |
| 90d | 22 | +81.82% | -7.73% | +4.79% | -12.52% | -14.50% | — |
| 180d | 22 | +27.27% | +24.60% | +5.36% | +19.24% | +21.91% | — |
| 1y | 22(2 pending) | +20.00% | +24.52% | +11.52% | +13.00% | +25.60% | — |
| 2y | 22(8 pending) | +100.00% | -7.87% | +29.23% | -37.10% | -37.43% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 875,000 | — | — | 875,000 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 240,000 | — | — | 240,000 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 37,656 | $14.09 | $530.6K | 1,247,447 | Aug 20, 2025 | Aug 21, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 12,344 | $14.03 | $173.1K | 1,285,103 | Aug 19, 2025 | Aug 21, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 767,600 | — | — | 767,600 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 261,900 | — | — | 261,900 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $11.67 | $583.6K | 1,297,447 | Dec 17, 2024 | Dec 19, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $11.67 | $583.5K | 1,098,499 | Dec 17, 2024 | Dec 19, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $13.17 | $658.3K | 1,246,494 | Dec 10, 2024 | Dec 11, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $13.16 | $658.2K | 1,148,499 | Dec 10, 2024 | Dec 11, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE CHIEF MEDICAL OFFICER | 13,789 | $1.44 | $19.9K | 3,421,636 | Dec 6, 2024 | Dec 9, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE CHIEF MEDICAL OFFICER | 11,876 | $8.42 | $100.0K | 3,433,512 | Dec 6, 2024 | Dec 9, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE CHIEF MEDICAL OFFICER | 11,876 | — | — | 338,124 | Dec 6, 2024 | Dec 9, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE CHIEF MEDICAL OFFICER | 11,876 | $8.42 | $100.0K | 4,327,189 | Dec 6, 2024 | Dec 9, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE CHIEF MEDICAL OFFICER | 11,876 | — | — | 1,088,124 | Dec 6, 2024 | Dec 9, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE CHIEF MEDICAL OFFICER | 13,789 | — | — | 20,684 | Dec 6, 2024 | Dec 9, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $13.95 | $697.5K | 1,347,447 | Nov 19, 2024 | Nov 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $13.95 | $697.5K | 1,198,499 | Nov 19, 2024 | Nov 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 45,124 | $16.76 | $756.3K | 1,253,375 | Nov 12, 2024 | Nov 14, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 45,045 | $16.76 | $754.9K | 1,301,449 | Nov 12, 2024 | Nov 14, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 4,955 | $17.64 | $87.4K | 1,296,494 | Nov 12, 2024 | Nov 14, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 4,876 | $17.64 | $86.0K | 1,248,499 | Nov 12, 2024 | Nov 14, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $14.88 | $743.8K | 1,298,499 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 1,450 | $15.25 | $22.1K | 1,397,447 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 48,550 | $14.86 | $721.7K | 1,398,897 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $13.83 | $691.4K | 1,346,494 | Oct 8, 2024 | Oct 10, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $13.83 | $691.4K | 1,348,499 | Oct 8, 2024 | Oct 10, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $12.93 | $646.7K | 1,398,499 | Sep 17, 2024 | Sep 19, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $12.93 | $646.5K | 1,447,447 | Sep 17, 2024 | Sep 19, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $11.50 | $574.9K | 1,448,499 | Sep 10, 2024 | Sep 12, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $11.50 | $574.9K | 1,396,494 | Sep 10, 2024 | Sep 12, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 36,216 | $14.76 | $534.5K | 1,512,283 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,756 | $15.61 | $183.5K | 1,499,747 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,523 | $15.62 | $180.0K | 1,500,760 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 2,300 | $16.26 | $37.4K | 1,497,447 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 35,944 | $14.76 | $530.4K | 1,511,503 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 2,261 | $16.25 | $36.7K | 1,498,499 | Aug 20, 2024 | Aug 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 35,363 | $12.77 | $451.4K | 1,548,499 | Aug 13, 2024 | Aug 15, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 35,401 | $12.76 | $451.9K | 1,446,494 | Aug 13, 2024 | Aug 15, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 14,599 | $11.78 | $171.9K | 1,481,895 | Aug 13, 2024 | Aug 15, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 14,637 | $11.77 | $172.3K | 1,583,862 | Aug 13, 2024 | Aug 15, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $11.40 | $570.2K | 1,598,499 | Jul 16, 2024 | Jul 18, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $11.40 | $570.1K | 1,547,447 | Jul 16, 2024 | Jul 18, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $9.62 | $480.9K | 1,496,494 | Jul 9, 2024 | Jul 11, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $9.62 | $480.8K | 1,648,499 | Jul 9, 2024 | Jul 11, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 48,028 | $9.14 | $439.2K | 1,698,499 | Jun 12, 2024 | Jun 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 47,834 | $9.15 | $437.5K | 1,546,494 | Jun 12, 2024 | Jun 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 1,972 | $9.00 | $17.8K | 1,746,527 | Jun 11, 2024 | Jun 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 2,166 | $9.00 | $19.5K | 1,594,328 | Jun 11, 2024 | Jun 13, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 44,350 | $9.06 | $401.7K | 1,748,499 | May 16, 2024 | May 16, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 44,746 | $9.06 | $405.3K | 1,597,447 | May 16, 2024 | May 16, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 2,766 | $9.04 | $25.0K | 1,792,849 | May 15, 2024 | May 16, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 2,381 | $9.05 | $21.6K | 1,642,193 | May 15, 2024 | May 16, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 2,873 | $9.01 | $25.9K | 1,644,574 | May 14, 2024 | May 16, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 2,884 | $9.01 | $26.0K | 1,795,615 | May 14, 2024 | May 16, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $9.34 | $467.1K | 1,596,494 | May 7, 2024 | May 9, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $9.34 | $467.2K | 1,798,499 | May 7, 2024 | May 9, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE CHIEF MEDICAL OFFICER | 82,733 | — | — | 0 | Apr 23, 2024 | Apr 24, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE CHIEF MEDICAL OFFICER | 82,733 | $0.84 | $69.5K | 3,359,587 | Apr 23, 2024 | Apr 24, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE CHIEF MEDICAL OFFICER | 48,260 | $1.44 | $69.5K | 3,407,847 | Apr 23, 2024 | Apr 24, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE CHIEF MEDICAL OFFICER | 48,260 | — | — | 34,473 | Apr 23, 2024 | Apr 24, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE CHIEF MEDICAL OFFICER | 119,047 | $0.84 | $100.0K | 4,245,869 | Apr 19, 2024 | Apr 22, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE CHIEF MEDICAL OFFICER | 119,047 | — | — | 117,333 | Apr 19, 2024 | Apr 22, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE CHIEF MEDICAL OFFICER | 69,444 | — | — | 166,936 | Apr 19, 2024 | Apr 22, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASE CHIEF MEDICAL OFFICER | 69,444 | $1.44 | $100.0K | 4,315,313 | Apr 19, 2024 | Apr 22, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $9.28 | $464.0K | 1,647,447 | Apr 16, 2024 | Apr 17, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $9.28 | $464.0K | 1,848,499 | Apr 16, 2024 | Apr 17, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $9.28 | $463.9K | 1,646,494 | Apr 9, 2024 | Apr 10, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 50,000 | $9.28 | $463.9K | 1,898,499 | Apr 9, 2024 | Apr 10, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 47,635 | $9.12 | $434.6K | 1,697,447 | Mar 25, 2024 | Mar 26, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 47,632 | $9.12 | $434.6K | 1,948,499 | Mar 25, 2024 | Mar 26, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 1,326 | $9.01 | $12.0K | 1,996,131 | Mar 22, 2024 | Mar 26, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 1,017 | $9.03 | $9.2K | 1,745,082 | Mar 22, 2024 | Mar 26, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 372 | $9.00 | $3.3K | 1,746,099 | Mar 21, 2024 | Mar 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 100 | $9.00 | $900 | 1,997,457 | Mar 21, 2024 | Mar 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 976 | $9.03 | $8.8K | 1,746,471 | Mar 19, 2024 | Mar 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 942 | $9.04 | $8.5K | 1,997,557 | Mar 19, 2024 | Mar 21, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 48,295 | $9.14 | $441.5K | 1,696,494 | Mar 15, 2024 | Mar 15, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 48,461 | $9.14 | $443.0K | 1,998,499 | Mar 15, 2024 | Mar 15, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 205 | $9.00 | $1.8K | 1,744,789 | Mar 14, 2024 | Mar 15, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 239 | $9.00 | $2.2K | 2,046,960 | Mar 14, 2024 | Mar 15, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 1,500 | $9.00 | $13.5K | 1,744,994 | Mar 13, 2024 | Mar 15, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 1,300 | $9.00 | $11.7K | 2,047,199 | Mar 13, 2024 | Mar 15, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 1,982 | $9.01 | $17.9K | 2,048,499 | Feb 29, 2024 | Mar 1, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 1,000 | $9.02 | $9.0K | 1,747,447 | Feb 29, 2024 | Mar 1, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 800 | $9.02 | $7.2K | 1,746,494 | Feb 29, 2024 | Mar 1, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 24,303 | $9.02 | $219.2K | 1,748,447 | Feb 28, 2024 | Feb 28, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 25,456 | $9.02 | $229.6K | 1,747,294 | Feb 28, 2024 | Feb 28, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 49,019 | $9.02 | $442.2K | 2,050,481 | Feb 28, 2024 | Feb 28, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 500 | $9.01 | $4.5K | 2,099,500 | Feb 26, 2024 | Feb 28, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 100 | $9.01 | $901 | 1,772,750 | Feb 26, 2024 | Feb 28, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 880,000 | — | — | 880,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 300,000 | — | — | 300,000 | Jan 2, 2024 | Jan 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALEGRANT Gift | 1,050,000 | — | — | 3,276,854 | May 17, 2023 | Jan 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Gift | 1,050,000 | — | — | 2,100,000 | May 17, 2023 | Jan 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | SALEGRANT Gift | 1,050,000 | — | — | 4,126,822 | May 17, 2023 | Jan 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Gift | 1,050,000 | — | — | 1,050,000 | May 17, 2023 | Jan 4, 2024 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,100,000 | — | — | 1,100,000 | Jan 3, 2023 | Jan 5, 2023 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 350,000 | — | — | 350,000 | Jan 3, 2023 | Jan 5, 2023 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 236,380 | — | — | 236,380 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 4,326,854 | — | — | 4,326,854 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 82,733 | — | — | 82,733 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 82,733 | — | — | 82,733 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 4,326,854 | — | — | 4,326,854 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |
| SPRY ARS PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,772,850 | — | — | 1,772,850 | Nov 8, 2022 | Nov 10, 2022 ↗ | View → |